We subsequently used the dbCoRC tool to developed a CRC model for AML patients, incorporating several classic transcription factors in AML such as ETV6, RUNX2, MEF2D, IRF1, and ELF1 [19, 24, 25]. This evidence concerns the gene RUNX2 and colorectal carcinoma.